questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines de tissu nerveux
Peptide natriurétique cérébral
Peptide natriurétique cérébral : Questions médicales fréquentes
Diagnostic
5
Peptide natriurétique
Diagnostic médical
Insuffisance cardiaque
Echocardiographie
Insuffisance cardiaque
Pathologie cardiaque
Symptômes
5
Douleurs thoraciques
Problèmes cardiaques
Pression artérielle
Excrétion de sodium
Troubles respiratoires
Insuffisance cardiaque
Prévention
5
Mode de vie sain
Hypertension
Stress
Problèmes cardiaques
Contrôles médicaux
Problèmes cardiaques
Traitements
5
Insuffisance cardiaque
Diurétiques
Médicaments
Inhibiteurs de l'ECA
Hospitalisation
Décompensation cardiaque
Changements de mode de vie
Alimentation saine
Suivi médical
Insuffisance cardiaque
Complications
5
Insuffisance cardiaque
Hypertension
Maladies rénales
Fonction rénale
Hospitalisations
Insuffisance cardiaque
Mortalité
Cardiovasculaire
Facteurs de risque
5
Tabagisme
Maladies cardiaques
Obésité
Insuffisance cardiaque
Sédentarité
Problèmes cardiaques
Stress chronique
Problèmes cardiaques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Peptide natriurétique cérébral : Questions médicales les plus fréquentes",
"headline": "Peptide natriurétique cérébral : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Peptide natriurétique cérébral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-26",
"dateModified": "2025-12-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Peptide natriurétique cérébral"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de tissu nerveux",
"url": "https://questionsmedicales.fr/mesh/D009419",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de tissu nerveux",
"code": {
"@type": "MedicalCode",
"code": "D009419",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.631"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Peptide natriurétique cérébral",
"alternateName": "Natriuretic Peptide, Brain",
"code": {
"@type": "MedicalCode",
"code": "D020097",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jens P Goetze",
"url": "https://questionsmedicales.fr/author/Jens%20P%20Goetze",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Biochemistry, Rigshospitalet University Hospital, Copenhagen, Denmark."
}
},
{
"@type": "Person",
"name": "Naoto Minamino",
"url": "https://questionsmedicales.fr/author/Naoto%20Minamino",
"affiliation": {
"@type": "Organization",
"name": "Omics Research Center, National Cerebral and Cardiovascular Center, Suita, Japan."
}
},
{
"@type": "Person",
"name": "Yasuaki Nakagawa",
"url": "https://questionsmedicales.fr/author/Yasuaki%20Nakagawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan."
}
},
{
"@type": "Person",
"name": "Toshio Nishikimi",
"url": "https://questionsmedicales.fr/author/Toshio%20Nishikimi",
"affiliation": {
"@type": "Organization",
"name": "Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan; Department of Internal Medicine, Wakakusa-Tatsuma Rehabilitation Hospital, Japan."
}
},
{
"@type": "Person",
"name": "Takekazu Miyoshi",
"url": "https://questionsmedicales.fr/author/Takekazu%20Miyoshi",
"affiliation": {
"@type": "Organization",
"name": "Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center, Suita, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Low atrial natriuretic peptide to brain natriuretic peptide ratio is associated with left atrial remodeling.",
"datePublished": "2023-05-09",
"url": "https://questionsmedicales.fr/article/37161971",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2459/JCM.0000000000001483"
}
},
{
"@type": "ScholarlyArticle",
"name": "Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38753384",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07853890.2024.2352603"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic accuracy of brain natriuretic peptide and N-terminal-pro brain natriuretic peptide to detect complications of cardiac transplantation in adults: A systematic review and meta-analysis.",
"datePublished": "2023-07-04",
"url": "https://questionsmedicales.fr/article/37433240",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.trre.2023.100774"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation.",
"datePublished": "2023-02-22",
"url": "https://questionsmedicales.fr/article/36823080",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2169/internalmedicine.1478-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of sacubitril/valsartan on brain natriuretic peptide level and prognosis of acute cerebral infarction.",
"datePublished": "2023-09-21",
"url": "https://questionsmedicales.fr/article/37733793",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0291754"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de tissu nerveux",
"item": "https://questionsmedicales.fr/mesh/D009419"
},
{
"@type": "ListItem",
"position": 5,
"name": "Peptide natriurétique cérébral",
"item": "https://questionsmedicales.fr/mesh/D020097"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Peptide natriurétique cérébral - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Peptide natriurétique cérébral",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Peptide natriurétique cérébral",
"description": "Comment mesurer le taux de PNC ?\nQuels tests sont utilisés pour évaluer l'insuffisance cardiaque ?\nQuels symptômes indiquent un test de PNC ?\nLe PNC est-il un bon marqueur de pronostic ?\nComment interpréter un taux élevé de PNC ?",
"url": "https://questionsmedicales.fr/mesh/D020097#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Peptide natriurétique cérébral",
"description": "Quels sont les symptômes d'un excès de PNC ?\nLe PNC peut-il causer des douleurs thoraciques ?\nComment le PNC affecte-t-il la pression artérielle ?\nQuels signes cliniques sont associés au PNC ?\nLe PNC est-il lié à des troubles respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D020097#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Peptide natriurétique cérébral",
"description": "Comment prévenir l'augmentation du PNC ?\nL'alimentation influence-t-elle le PNC ?\nLe stress affecte-t-il le PNC ?\nL'exercice régulier aide-t-il à réduire le PNC ?\nLes contrôles médicaux réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D020097#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Peptide natriurétique cérébral",
"description": "Comment traiter un excès de PNC ?\nLes médicaments affectent-ils le PNC ?\nLe PNC nécessite-t-il une hospitalisation ?\nQuels traitements non médicamenteux sont recommandés ?\nLe PNC nécessite-t-il un suivi régulier ?",
"url": "https://questionsmedicales.fr/mesh/D020097#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Peptide natriurétique cérébral",
"description": "Quelles complications peuvent survenir avec un PNC élevé ?\nLe PNC est-il lié à des maladies rénales ?\nLe PNC peut-il entraîner des hospitalisations fréquentes ?\nDes niveaux élevés de PNC augmentent-ils le risque d'AVC ?\nLe PNC est-il un indicateur de mortalité ?",
"url": "https://questionsmedicales.fr/mesh/D020097#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Peptide natriurétique cérébral",
"description": "Quels sont les principaux facteurs de risque pour le PNC ?\nLe tabagisme influence-t-il le PNC ?\nL'obésité est-elle un facteur de risque pour le PNC ?\nLe manque d'exercice affecte-t-il le PNC ?\nLe stress chronique influence-t-il le PNC ?",
"url": "https://questionsmedicales.fr/mesh/D020097#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le taux de PNC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de PNC se mesure par un test sanguin spécifique en laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'insuffisance cardiaque ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échocardiographie et la mesure des niveaux de PNC."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un test de PNC ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'essoufflement ou l'œdème peuvent justifier un test de PNC."
}
},
{
"@type": "Question",
"name": "Le PNC est-il un bon marqueur de pronostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de PNC sont associés à un pronostic défavorable en cardiologie."
}
},
{
"@type": "Question",
"name": "Comment interpréter un taux élevé de PNC ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé de PNC peut indiquer une insuffisance cardiaque ou d'autres pathologies cardiaques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un excès de PNC ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent essoufflement, fatigue, et œdème des membres inférieurs."
}
},
{
"@type": "Question",
"name": "Le PNC peut-il causer des douleurs thoraciques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le PNC lui-même ne cause pas de douleurs thoraciques, mais il indique des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Comment le PNC affecte-t-il la pression artérielle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le PNC aide à réduire la pression artérielle en favorisant l'excrétion de sodium et d'eau."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés au PNC ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent tachycardie, hypertension et signes d'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Le PNC est-il lié à des troubles respiratoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de PNC peuvent être associés à des troubles respiratoires en cas d'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'augmentation du PNC ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, contrôler la pression artérielle et éviter le tabac."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le PNC ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en sodium peut aggraver les niveaux de PNC et l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le PNC ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les problèmes cardiaques et augmenter les niveaux de PNC."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à réduire le PNC ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé cardiaque et réduire les niveaux de PNC."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers aident à détecter précocement les problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Comment traiter un excès de PNC ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement vise à gérer l'insuffisance cardiaque sous-jacente et peut inclure des diurétiques."
}
},
{
"@type": "Question",
"name": "Les médicaments affectent-ils le PNC ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments comme les inhibiteurs de l'ECA peuvent réduire les niveaux de PNC."
}
},
{
"@type": "Question",
"name": "Le PNC nécessite-t-il une hospitalisation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une hospitalisation peut être nécessaire si les niveaux de PNC indiquent une décompensation cardiaque."
}
},
{
"@type": "Question",
"name": "Quels traitements non médicamenteux sont recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de mode de vie, comme une alimentation saine et l'exercice, sont conseillés."
}
},
{
"@type": "Question",
"name": "Le PNC nécessite-t-il un suivi régulier ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est important pour surveiller l'évolution de l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un PNC élevé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'insuffisance cardiaque, l'hypertension et des arythmies."
}
},
{
"@type": "Question",
"name": "Le PNC est-il lié à des maladies rénales ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de PNC peuvent indiquer une détérioration de la fonction rénale."
}
},
{
"@type": "Question",
"name": "Le PNC peut-il entraîner des hospitalisations fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de PNC sont souvent associés à des hospitalisations pour insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Des niveaux élevés de PNC augmentent-ils le risque d'AVC ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un PNC élevé peut être un facteur de risque pour les accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Le PNC est-il un indicateur de mortalité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de PNC sont associés à un risque accru de mortalité cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le PNC ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète, et les antécédents familiaux de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le PNC ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque majeur pour les maladies cardiaques et le PNC élevé."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque pour le PNC ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité augmente le risque d'insuffisance cardiaque et de niveaux élevés de PNC."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice affecte-t-il le PNC ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut contribuer à des niveaux élevés de PNC et à des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Le stress chronique influence-t-il le PNC ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut aggraver les problèmes cardiaques et augmenter le PNC."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/12/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Clinical Biochemistry, Rigshospitalet University Hospital, Copenhagen, Denmark.
Publications dans "Peptide natriurétique cérébral" :
3 publications dans cette catégorie
Affiliations :
Omics Research Center, National Cerebral and Cardiovascular Center, Suita, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan; Department of Internal Medicine, Wakakusa-Tatsuma Rehabilitation Hospital, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center, Suita, Japan.
Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center, Suita, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Division of Intensive Care Unit, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inzai, Chiba 270-1694, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry (MM, KK), National Cerebral and Cardiovascular Center, Japan.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Cardiorenal Research Laboratory, Department of Cardiovascular Diseases, Department of Physiology and Bioengineering, College of Medicine Mayo Clinic, Rochester, MN, USA. Electronic address: burnett.john@mayo.edu.
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Vanderbilt Translational and Clinical Cardiovascular Research Center, University Medical Center, Nashville, TN (H.F.-T., J.F.F., K.N.B., D.K.G).
Veterans Health Administration, Tennessee Valley Healthcare System, Clinical Sciences Research and Development, Nashville, TN (K.N.B.).
Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (K.N.B.).
Publications dans "Peptide natriurétique cérébral" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX (T.J.W.).
Publications dans "Peptide natriurétique cérébral" :
Atrial natriuretic peptide (ANP) deficiency is thought to be one of the causes of heart failure induced by atrial fibrillation (AF). Although ANP deficiency is thought to occur as a result of atrial r...
In total, 373 consecutive patients who underwent initial ablation for persistent AF [age, 67 ± 10 years; female, 97 (26%)] were retrospectively enrolled. ANP and brain natriuretic peptide (BNP) were m...
The median ANP level was 116 (71-178) pg/ml and the median ANP/BNP ratio was 0.65 (0.46-1.00). The ANP/BNP ratio decreased with increasing left atrial volume index or LVAs and with decreasing left atr...
Secretion of ANP relative to BNP decreased with progression of left atrial remodeling in patients with AF ablation. Furthermore, prognosis of heart failure was poor in patients with a low ANP/BNP rati...
Pulmonary hypertension (PH) is a life-threatening disease, especially in paediatric population. Symptoms of paediatric PH are non-specific. Accurate detection of paediatric PH is helpful for early tre...
PubMed, Web of Science, Cochrane Library and Embase databases were screened since their respective inceptions until August 2023. A bivariate random model and a hierarchical summary receiver operating ...
Eighteen studies using BNP/NT-proBNP were assessed, comprising 1127 samples. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds rati...
Both BNP and NT-proBNP are good markers for differentiating paediatric PH patients from non-PH individuals....
We aimed to evaluate the utility of BNP and NT-proBNP in identifying adverse recipient outcomes following cardiac transplantation....
We searched MEDLINE (Ovid), Embase (Ovid), and the Cochrane Library from inception to February 2023. We included studies reporting associations between BNP or NT-proBNP and adverse outcomes following ...
Thirty-two studies involving 2,297 cardiac transplantation recipients were included. We report no significant association between BNP or NT-proBNP and significant acute cellular rejection of grade 3A ...
In isolation, serum BNP and NT-proBNP lack sufficient sensitivity and specificity to reliably predict adverse outcomes following cardiac transplantation....
Objective The association between natriuretic peptide levels in atrial fibrillation (AF) patients with advanced left atrial (LA) remodeling and reverse remodeling after rhythm control therapy has not ...
Previous studies demonstrated that elevated brain natriuretic peptide (BNP) level is associated with adverse clinical outcomes of acute cerebral infarction (ACI). Researchers hypothesized that BNP mig...
In a randomized, controlled, parallel-group trial of patients with ACI within 48 hours of symptom onset and need for antihypertensive therapy, patients have randomized within 24 hours to sacubitril/va...
We evaluated 80 eligible patients admitted to the Stroke Center of Lianyungang Second People's Hospital between 1st May, 2021 and 31st June, 2022. Except for 28 patients excluded before randomization ...
Sacubitril/valsartan reduced endogenous plasma BNP levels in patients with ACI and did not affect their short-term prognosis....
Natriuretic peptides must be interpreted in their clinical context, especially in intensive care medicine. This overview presents the diagnostic, prognostic, and therapeutic significance of B‑type nat...
Early identification of patients with sepsis at high risk of death remains a challenge, and whether brain natriuretic peptide (BNP) or N-terminal pro-B-type natriuretic peptide (NT-proBNP) has a progn...
We searched five databases to identify studies that met the inclusion criteria. The primary outcomes were the pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood rati...
Forty-seven studies were included in our meta-analysis. The pooled sensitivity of NT-proBNP (0.77 [0.68, 0.84]) was weaker than that of BNP (0.82 [0.76, 0.87]), the pooled specificity of NT-proBNP (0....
Elevated levels of BNP and NT-proBNP were significantly related to the mortality of patients with sepsis and had a moderate prognostic value in predicting the mortality of patients with sepsis. In add...
Heart failure (HF) is a dominant health problem with an overall poor prognosis. Natriuretic peptides (NPs) are upregulated in HF as a compensatory mechanism. They have been extensively used for diagno...
This review addresses the history and physiology of NPs in order to understand their current role in clinical practice. It further provides a detailed and updated narrative review on the utility of th...
NPs show excellent predictive ability in heart failure patients, both in acute and chronic settings. Understanding their pathophysiology and their modifications in specific situations is key for an ad...
N terminal pro brain natriuretic peptide (NT-proBNP) plays an important role in the diagnosis and prognosis of heart failure (HF). The plasma level of NT-proBNP in atrial fibrillation (AF) patients wa...
Heart failure in elderly individuals poses significant challenges due to the decline in cardiac function associated with aging. This study aimed to investigate the clinical efficacy of recombinant hum...
This was a retrospective case control study of the medical records of 60 elderly patients with heart failure admitted to our hospital between December 2020 and December 2023. Patients were divided int...
Posttreatment BNP levels were significantly lower in the observation group than in the control group (p < 0.05), and the total clinical effective rate was greater in the observation group (p < 0.05). ...
RhBNP demonstrated ideal clinical efficacy in elderly patients with heart failure, improving symptoms and indicating potential for widespread use in the future....